Description of the medicine: Phosphocreatine (Fosfocreatine)
1- (2-hydroxyethyl) phosphatylguanidine hydrophosphate.
Synonyms: Creatine phosphate, Creatine phosphate, Neoton, Creatinfosfat, Neoton.
Phosphocreatine is a permanent component of muscles (including myocardium). It plays an important role in providing energy processes of contractile activity of muscles.
It improves myocardial metabolism, intracellular energy transport, inhibits the destruction of sarcolemma of ischemic cardiomyocytes.
Synthetic phosphocreatine is used as a “metabolic” agent in the complex therapy (and prevention) of various disorders of the myocardial functional activity, including in case of chronic heart failure.
Enter intramuscularly at 0.5-1 g or intravenously at 1-2 g per day. In acute myocardial ischemia, administered intravenously: on the 1st day - 2 g bolus, then 4 g drip per hour for 2 hours; on days 2-6, daily for 4-8 g.
The drug is usually well tolerated, however, with rapid intravenous administration, a drop in blood pressure is possible.
Release form: lyophilized powder for injection solutions in bottles of 0.5; one; 2 and 5 g complete with solvent (in ampoules).